
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Showing 26-50 of 112 citing articles:
Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms
Jixuan Zheng, Jinting Jiang, Yicheng Pu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
Jixuan Zheng, Jinting Jiang, Yicheng Pu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
Phenotypic plasticity and increased infiltration of peripheral blood-derived TREM1+ mono-macrophages following radiotherapy in rectal cancer
Haihong Wang, Menglan Zhai, Mingjie Li, et al.
Cell Reports Medicine (2025), pp. 101887-101887
Closed Access
Haihong Wang, Menglan Zhai, Mingjie Li, et al.
Cell Reports Medicine (2025), pp. 101887-101887
Closed Access
Metabolites and metabolic pathway reactions links to sensitization of immunotherapy in pan-cancer
Shaobo Yu, Yuzhen Gao, Feng Zhao, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200933-200933
Open Access
Shaobo Yu, Yuzhen Gao, Feng Zhao, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200933-200933
Open Access
Rational Design of Single‐Atom Nanozymes for Combination Cancer Immunotherapy
Hanchao Lin, Yonghui Gao, Le Zhu, et al.
Advanced Functional Materials (2025)
Closed Access
Hanchao Lin, Yonghui Gao, Le Zhu, et al.
Advanced Functional Materials (2025)
Closed Access
Reshaping the immune microenvironment and reversing immunosenescence by natural products: prospects for immunotherapy in gastric cancer
Zhipeng Cao, Zhilin Wang, Yang Li, et al.
Seminars in Cancer Biology (2025) Vol. 110, pp. 1-16
Closed Access
Zhipeng Cao, Zhilin Wang, Yang Li, et al.
Seminars in Cancer Biology (2025) Vol. 110, pp. 1-16
Closed Access
Comprehensive Bioinformatics Analyses and Experimental Validation of the Cell Cycle Related Protein SAPCD2 as a New Biomarker and Potential Therapeutic Target in Pancreatic Cancer
Yuting Liu, Bo Li, Lingling Ke, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2855-2877
Open Access
Yuting Liu, Bo Li, Lingling Ke, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2855-2877
Open Access
Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines
Weijiang Liu, Hong Su, Peng Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Weijiang Liu, Hong Su, Peng Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Is it time to revisit the significance of PD-L1 expression in assisting our treatment decisions?
Georgios Papageorgiou, Nikolaos Skouteris, Maria Grenzelia, et al.
Immunotherapy (2025), pp. 1-5
Closed Access
Georgios Papageorgiou, Nikolaos Skouteris, Maria Grenzelia, et al.
Immunotherapy (2025), pp. 1-5
Closed Access
Nucleic acid coated photothermal nanoregulator for multiple therapy of drug-resistant breast cancer
Yuxin Shen, Yixin Wen, Sen Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 308, pp. 142592-142592
Closed Access
Yuxin Shen, Yixin Wen, Sen Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 308, pp. 142592-142592
Closed Access
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy
Amirhoushang Poorkhani, Mahboubeh Tajaldini, Farahnazsadat Ahmadi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Amirhoushang Poorkhani, Mahboubeh Tajaldini, Farahnazsadat Ahmadi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Tellurium-driven maple leaf-shaped manganese nanotherapeutics reshape tumor microenvironment via chemical transition in situ to achieve highly efficient radioimmunotherapy of triple negative breast cancer
Wei Huang, Sujiang Shi, Haoran Lv, et al.
Bioactive Materials (2023) Vol. 27, pp. 560-573
Open Access | Times Cited: 12
Wei Huang, Sujiang Shi, Haoran Lv, et al.
Bioactive Materials (2023) Vol. 27, pp. 560-573
Open Access | Times Cited: 12
Deciphering the molecular and cellular atlas of immune cells in septic patients with different bacterial infections
Ping Sun, Mintian Cui, Jiongjie Jing, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Ping Sun, Mintian Cui, Jiongjie Jing, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer
Lei Wang, Han Zhou, Qingjing Chen, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 12
Lei Wang, Han Zhou, Qingjing Chen, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 12
Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy
Zhihong Sun, Zhuokai Sun, Jie Liu, et al.
Small (2023) Vol. 20, Iss. 12
Closed Access | Times Cited: 11
Zhihong Sun, Zhuokai Sun, Jie Liu, et al.
Small (2023) Vol. 20, Iss. 12
Closed Access | Times Cited: 11
Liposome-based nanomedicine for immune checkpoint blocking therapy and combinatory cancer therapy
Haoyuan Zhou, Cui‐Yun Yu, Hua Wei
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123818-123818
Closed Access | Times Cited: 4
Haoyuan Zhou, Cui‐Yun Yu, Hua Wei
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123818-123818
Closed Access | Times Cited: 4
Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy
Shan-Shan Zhen, Wenqian Wang, Guohui Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Shan-Shan Zhen, Wenqian Wang, Guohui Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation
Han Zhou, Lei Wang, Zhiwen Lin, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007840-e007840
Open Access | Times Cited: 10
Han Zhou, Lei Wang, Zhiwen Lin, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007840-e007840
Open Access | Times Cited: 10
Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer
Chaoqiang Deng, Jiatao Liao, Zichen Fu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 2, pp. 292-306
Open Access | Times Cited: 3
Chaoqiang Deng, Jiatao Liao, Zichen Fu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 2, pp. 292-306
Open Access | Times Cited: 3
Recent advances in therapeutic engineered extracellular vesicles
Chenlu Yao, Hong Zhang, Chao Wang
Nanoscale (2024) Vol. 16, Iss. 16, pp. 7825-7840
Closed Access | Times Cited: 3
Chenlu Yao, Hong Zhang, Chao Wang
Nanoscale (2024) Vol. 16, Iss. 16, pp. 7825-7840
Closed Access | Times Cited: 3
Enhanced Osteosarcoma Immunotherapy via CaCO3 Nanoparticles: Remodelling Tumour Acidic and Immune Microenvironment for Photodynamic Therapy
Y J Gao, Zhuoying Wang, Xinmeng Jin, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Y J Gao, Zhuoying Wang, Xinmeng Jin, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Malic enzymes in cancer: Regulatory mechanisms, functions, and therapeutic implications
Huan Wang, Wanlin Cui, Yue Song, et al.
Redox Biology (2024) Vol. 75, pp. 103273-103273
Open Access | Times Cited: 3
Huan Wang, Wanlin Cui, Yue Song, et al.
Redox Biology (2024) Vol. 75, pp. 103273-103273
Open Access | Times Cited: 3
STING Agonist Delivered by Neutrophil Membrane-Coated Gold Nanoparticles Exerts Synergistic Tumor Inhibition with Radiotherapy
Dehua Lu, Wenhua Li, Jingyun Tan, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 3
Dehua Lu, Wenhua Li, Jingyun Tan, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 3
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 3
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 3
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non‐Invasive Precision Medicine in Cancer Patients
Yusheng Guo, Tianxiang Li, Bingxin Gong, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Yusheng Guo, Tianxiang Li, Bingxin Gong, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3